business
QuidelOrtho looks to sell testing unit as PE circles healthcare companies
Diagnostic company’s shares are down 90% since its rapid antigen tests were the first to be approved for Covid-19
Read full story on Financial Times → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Financial Times alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop